ArticleHuman genomics2025
High-order single-nucleotide polymorphism interactions between selected anti-oxidant and protease genes influence North Indians' propensity for chronic obstructive pulmonary disease (COPD) and lung function parameters.
Article in Human genomics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCOPD causes persistent airflow restriction, oxidative stress, and inflammation. Proteins like MMP9, MMP12, and ADAM33, and antioxidant enzymes such as Glutathione Peroxidase, Superoxide Dismutase, and Catalase are crucial for lung homeostasis, and imbalances increase COPD risk.
methodsA case-control study was carried out with 500 healthy controls and 500 COPD patients. We did genotype on several SNPs in CAT, SOD1, SOD2, GPx, MMP9, MMP12, and ADAM33, and further MDR, CART, and logistic regression models were applied to examine gene-gene interactions, pulmonary function tests, and clinical symptoms.
resultsSNPs associated with higher COPD risk were SOD2 rs4880, CAT rs1001179, MMP9 rs17576, and ADAM33 rs612709. High-order combinations like SOD2 rs4880 and ADAM33 rs612709 (AOR = 1.44, p = 0.0001) and CAT rs1001179 and ADAM33 rs2280091 (AOR = 1.4, p = 0.0009) showed combinatorial effects. The risk of mucus was greatly lowered by numerous SOD2-based combinations, such as ADAM33 rs2280091, MMP9 rs17576, and MMP12 rs2276109. FEV1, FVC, and FEV1/FVC revealed genotype-specific disparities before and after bronchodilator usage. Combinations of SOD2 rs4880, ADAM33 rs612709, and MMP9 rs3918242 changed bronchodilator responses. MDR study exhibited that CAT (rs7943316) was the best single-locus model for risk prediction towards COPD patients. CART analysis showed SOD2 (rs4880) to be a disease risk factor.
conclusionThis study is the first to show high-order interactions between selected antioxidant and protease gene variations affecting COPD risk and lung function, specifically SOD2 rs4880, CAT rs1001179, and ADAM33 rs612709. The findings support the potential use of combinatorial genetic profiles in risk stratification and personalized therapeutic strategies for COPD.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.